Table 3.
Anti-CMV IgM(+) patients | Anti-CMV IgM(-)IgG(+) patients | |||
Su-positive | Su-negative | Su-positive | Su-negative | |
n | 6 | 14 | 9 | 30 |
U1RNP | 17% (1/6) | 43% (6/14) | 67% (6/9)* | 20% (6/30)* |
Sm | 0% (0/6) | 0% (0/14) | 33% (3/9) | 10% (3/30) |
Ribosomal P | 17% (1/6) | 7% (1/14) | 0% (0/9) | 13% (4/30) |
RNA helicase A | 17% (1/6) | 14% (2/14) | 33% (3/9) | 23% (7/30) |
Ro | 33% (2/6) | 36% (5/14) | 67% (6/9)† | 30% (9/30)2 |
La | 0% (0/6) | 21% (3/14) | 11% (1/9) | 7% (2/30) |
CMV, cytomegalovirus. *P = 0.0141, †P = 0.0631.